Cancer

New tool to determine the risk of prostate cancer death

Researchers at the University of Copenhagen have identified a new prognostic biomarker: the neuropeptide pro-NPY, which may help determine the risk of dying from prostate cancer. This particular type of protein is very specific ...

Jan 27, 2016
popularity2 comments 0

Better diagnosis for a rare syndrome

Understanding Li–Fraumeni syndrome (LFS)—a genetic disorder that substantially increases the risk of a young person developing cancer such as the bone cancer osteosarcoma—is a first step to improving diagnosis and counseling.

Jan 27, 2016
popularity82 comments 0